Patents by Inventor Weiguo Qing

Weiguo Qing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-OX40 ANTIBODY AND USES THEREOF
    Publication number: 20240301077
    Abstract: The present invention provides an anti-OX40 antibody or antigen-binding fragment thereof, a preparation method therefor and the use for treating OX40-related diseases or conditions.
    Type: Application
    Filed: May 22, 2024
    Publication date: September 12, 2024
    Applicant: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Yizhen YANG, Yu CAI, Xiong LI, Lei ZHOU, Weiguo QING, Wei-Guo SU
  • Anti-OX40 antibody and uses thereof
    Patent number: 12030951
    Abstract: The present invention provides an anti-OX40 antibody or antigen-binding fragment thereof, a preparation method therefor and the use for treating OX40-related diseases or conditions.
    Type: Grant
    Filed: August 18, 2022
    Date of Patent: July 9, 2024
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Yizhen Yang, Yu Cai, Xiong Li, Lei Zhou, Weiguo Qing, Wei-Guo Su
  • ANTI-OX40 ANTIBODY AND USES THEREOF
    Publication number: 20230242657
    Abstract: Provided are an anti-OX40 antibody or antigen-binding fragment thereof, a preparation method thereof and the use for treating OX40-related diseases or conditions.
    Type: Application
    Filed: April 16, 2021
    Publication date: August 3, 2023
    Inventors: Yizhen YANG, Yu CAI, Xiong LI, Lei ZHOU, Weiguo QING, Wei-Guo SU
  • ANTI-OX40 ANTIBODY AND USES THEREOF
    Publication number: 20230151105
    Abstract: The present invention provides an anti-OX40 antibody or antigen-binding fragment thereof, a preparation method therefor and the use for treating OX40-related diseases or conditions.
    Type: Application
    Filed: August 18, 2022
    Publication date: May 18, 2023
    Inventors: Yizhen YANG, Yu CAI, Xiong LI, Lei ZHOU, Weiguo QING, Wei-Guo SU
  • Tumor models employing green fluorescent protein
    Patent number: 7749486
    Abstract: The present invention relates to a LOX-GFP marker and methods of analyzing tumor burden in ascites or in lung. The invention also relates to a new LOX-GFP-LM cell line which demonstrates increased lung metastasis. The methods of the invention result in better quantitative tumor burden assessment and improved efficacy evaluation. These improved models provide a feasible alternative for ascites or experimental metastasis evaluation of novel cancer therapeutics.
    Type: Grant
    Filed: March 26, 2007
    Date of Patent: July 6, 2010
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Weiguo Qing
  • Tumor models employing green fluorescent protein
    Publication number: 20070231789
    Abstract: The present invention relates to a LOX-GFP marker and methods of analyzing tumor burden in ascites or in lung. The invention also relates to a new LOX-GFP-LM cell line which demonstrates increased lung metastasis. The methods of the invention result in better quantitative tumor burden assessment and improved efficacy evaluation. These improved models provide a feasible alternative for ascites or experimental metastasis evaluation of novel cancer therapeutics.
    Type: Application
    Filed: March 26, 2007
    Publication date: October 4, 2007
    Inventor: Weiguo Qing